Deadly Germs Largely Ignored By Drug Firms

"It is likely to be several years before new drugs to treat Gram-negative infections are available. A report last September by European health authorities found only six novel drugs in clinical trials that might work against at least one Gram-negative organism, compared with 13 for Gram-positive bacteria."

Andrew Pollack
New York Times
February 26, 2010

Read article @